Mikra Applies to Health Canada for CELLF 2.0 NPN
TORONTO, July 08, 2024 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, reports that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. (“Mikra”) has filed a Natural Health Product License Application (“PLA”) with Health Canada, seeking a Natural Product Number (“NPN”) for its best-selling cellular health product CELLF 2.0.
Related news for (LFSWF)
- Lifeist Wellness Inc. Launches Mikra’s Mind-First Movement, Redefining High-Performance Excellence
- Lifeist Announces Acquisition of High-Potency Vape IP
- Lifeist Chairman’s Letter to Shareholders
- Lifeist Confirms Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders
- Lifeist Reports Second Quarter 2024 Financial Results